Page last updated: 2024-08-24

iobitridol and fluorodeoxyglucose f18

iobitridol has been researched along with fluorodeoxyglucose f18 in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antoch, G; Bockisch, A; Debatin, JF; Egelhof, T; Freudenberg, LS; Jentzen, W; Stattaus, J	1
Antoch, G; Bockisch, A; Forsting, M; Kuehl, H; Stergar, H; Veit, P	1
Aerts, HJ; Backes, WH; Buijsen, J; Janssen, MH; Kierkels, RG; Lambin, P; Lammering, G; Ollers, MC	1
Choi, JY; Franks, TJ; Han, J; Kim, HK; Kim, TJ; Lee, KS; Zo, J	1

Trials

1 trial(s) available for iobitridol and fluorodeoxyglucose f18

Article	Year
Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. European radiology, 2006, Volume: 16, Issue:1 Topics: Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iohexol; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2006

Article

Year

Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results.

European radiology, 2006, Volume: 16, Issue:1

Topics: Aged; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iohexol; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed

2006

Other Studies

3 other study(ies) available for iobitridol and fluorodeoxyglucose f18

Article	Year
Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:10 Topics: Artifacts; Body Surface Area; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Iohexol; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: sequential perfusion-CT findings. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2010, Volume: 94, Issue:2 Topics: Contrast Media; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Iohexol; Male; Neoplasm Staging; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Statistics, Nonparametric; Tomography, Emission-Computed; Tomography, X-Ray Computed	2010
Colloid Adenocarcinoma of the Lung: CT and PET/CT Findings in Seven Patients. AJR. American journal of roentgenology, 2018, Volume: 211, Issue:2 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Combined Modality Therapy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iohexol; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed	2018